Angeles Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Angeles Wealth Management's PFE Position: Q1 2026 in Review
Angeles Wealth Management increased its Pfizer (PFE) stake by 17% in Q1 2026, buying an estimated $63.3K and bringing the position to 16,651 shares worth $468K. The position accounts for 0.03% of the portfolio, ranked #241.
Angeles Wealth Management first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $787K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Angeles Wealth Management held 16,651 shares of Pfizer worth $468K as of Q1 2026.
- Angeles Wealth Management bought 2,378 Pfizer shares in Q1 2026, an estimated $63.3K.
- Pfizer made up 0.03% of Angeles Wealth Management's portfolio in Q1 2026, its #241 holding.
- Angeles Wealth Management first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
- Angeles Wealth Management's Pfizer position peaked at $787K in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.